Key result
Artificial intelligence and machine learning in cardiovascular medicine offer potential for improved diagnosis, risk prediction, and treatment guidance using imaging and electronic health records.
Why the study?
Large, heterogeneous electronic datasets and imaging from CVD patients have created a need to leverage AI for classification, diagnosis, risk prediction, and treatment guidance.
Artificial intelligence and machine learning hold significant potential to improve diagnostic accuracy, workflow efficiency, and personalized care in cardiovascular medicine and imaging.
AI may enhance CV diagnosis and workflows; leaves open prospective validation before clinical adoption.
The collection of large, heterogeneous electronic datasets and imaging from patients with cardiovascular disease (CVD) has lent itself to the use of sophisticated analysis using artificial intelligence (AI). AI techniques such as machine learning (ML) are able to identify relationships between data points by linking input to output variables using a combination of different functions, such as neural networks. In cardiovascular medicine, this is especially pertinent for classification, diagnosis, risk prediction and treatment guidance. Common cardiovascular data sources from patients include genomic data, cardiovascular imaging, wearable sensors and electronic health records (EHR). Leveraging AI in analysing such data points: (I) for clinicians: more accurate and streamlined image interpretation and diagnosis; (II) for health systems: improved workflow and reductions in medical errors; (III) for patients: promoting health with further education and promoting primary and secondary cardiovascular health prevention. This review addresses the need for AI in cardiovascular medicine by reviewing recent literature in different cardiovascular imaging modalities: electrocardiography, echocardiography, cardiac computed tomography, cardiac nuclear imaging, and cardiac magnetic resonance (CMR) imaging as well as the role of EHR. This review aims to conceptulise these studies in relation to their clinical applications, potential limitations and future opportunities and directions.
No takes yet. Share an insight, caveat, or question.
Haq et al. (2021) conducted a review in Cardiovascular disease. Artificial intelligence was evaluated. Artificial intelligence and machine learning in cardiovascular medicine offer potential for improved diagnosis, risk prediction, and treatment guidance using imaging and electronic health records.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: